Vicore Pharma Holding AB (publ) (VCRE)

NASDAQ: VCRE · Real-Time Price · USD

15.03

0.00 (0.00%)

At close: Jul 7, 2026, 4:00 PM EDT

13.94

-1.09 (-7.22%)

Pre-market: Jul 8, 2026, 4:37 AM EDT

Vicore Pharma Holding AB Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 7, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	456	345	179	158	141	110
Market Cap Growth	-	92.70%	13.69%	12.08%	27.22%	-52.33%
Enterprise Value	347	254	145	103	124	61
PS Ratio	1231.68	833.44	18.13	-	-	-
PB Ratio	4.38	2.90	1.76	3.48	5.07	2.61
P/TBV Ratio	4.38	2.90	1.76	3.50	6.63	3.16
EV/Sales Ratio	935.98	614.46	14.65	-	-	-
Debt / Equity Ratio	-	-	-	-	0	0.00
Net Debt / Equity Ratio	-1.07	-1.06	-1.02	-1.06	-0.90	-0.97
Net Debt / EBITDA Ratio	-	2.58	6.15	1.52	0.92	1.28
Net Debt / FCF Ratio	2.60	3.11	7.01	1.93	0.87	1.40
Asset Turnover	0.00	0.00	0.13	-	-	-
Quick Ratio	12.57	9.99	17.90	11.86	5.69	5.67
Current Ratio	12.69	10.28	18.20	12.10	5.81	5.75
Return on Equity (ROE)	-47.19%	-42.92%	-21.28%	-83.53%	-85.79%	-80.37%
Return on Assets (ROA)	-28.12%	-23.53%	-14.05%	-47.99%	-45.54%	-42.76%
Return on Capital Employed (ROCE)	-49.00%	-41.30%	-16.80%	-70.20%	-98.60%	-76.10%
Earnings Yield	-10.92%	-15.01%	-8.51%	-19.63%	-19.69%	-29.68%
FCF Yield	-9.20%	-11.81%	-8.32%	-15.75%	-20.47%	-26.55%
Buyback Yield / Dilution	-50.17%	-75.30%	-41.72%	-33.71%	-3.64%	-28.44%